Ecolab Inc. Profile Avatar - Palmy Investing

Ecolab Inc.

Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences segment…
Chemicals - Specialty
US, Saint Paul [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 67% Positive
Leverage & Liquidity 17% Weak
Per Share Metrics 0% Bad
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -14.72 93.09 109.16
Graham Fair Price 1.71 30.53 30.02
PEG 100.00 28.05 0.00
Price/Book 12.82 7.94 7.03
Price/Cash Flow 51.56 145.39 95.93
Prices/Earnings 13.15 39.50 34.91
Price/Sales 20.79 17.36 14.37
Price/FCF 51.56 145.39 95.93
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 2.83 0.43 0.42
Operating Margin -7.02 0.15 0.16
ROA 4.32 0.02 0.02
ROE 0.05 0.05 -0.29
ROIC 0.03 0.03 8.37
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ -0.07 -0.03 -118.56
Dividends QOQ < 0.005 0.13 3308.50
EBIT QOQ 0.09 -0.11 26.54
EPS QOQ 0.00 0.01 100.00
FCF QOQ -0.05 -0.24 -377.75
Revenue QOQ < 0.005 -0.05 -851.44
Naive Interpretation member
03 - Financial Growth · Positive
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 59.12 66.27 12.09
Days Sales Outstanding (DSO) 69.04 70.91 2.71
Inventory Turnover 1.52 1.36 -10.79
Debt/Capitalization 0.51 0.48 -4.90
Quick Ratio 0.91 0.93 2.38
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 28.20 28.72 1.86
Cash 3.22 1.68 -47.88
Capex -0.92 -0.71 23.37
Free Cash Flow 2.07 1.57 -24.18
Revenue 13.80 13.13 -4.87
Naive Interpretation member
05 - Per Share Metrics · Bad
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.30 1.41 8.42
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 13.24 9.76 -26.33
Naive Interpretation Member
06 - Financial Health · Weak
End of ECL's Analysis
CIK: 31462 CUSIP: 278865100 ISIN: US2788651006 LEI: - UEI: -
Secondary Listings
ECL has no secondary listings inside our databases.